Eargo and hearX, two hearing aid companies, are merging with a $100 million investment from Patient Square Capital to become LXE Hearing, LXE CEO Nic Klopper tells Axios exclusively.
Why it matters: This marks the first merger in the over-the-counter (OTC) hearing aid market since the FDA established the regulatory category in 2022.
